{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T09:54:32Z","timestamp":1774605272371,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.abd.2023.09.005","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T22:58:01Z","timestamp":1712962681000},"page":"527-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of 0.5% colchicine cream versus 5% 5-fluorouracil cream in the treatment of cutaneous field cancerization: a randomized clinical trial"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9072-8913","authenticated-orcid":false,"given":"Amanda Soares","family":"Teixeira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3146-1892","authenticated-orcid":false,"given":"Ivanka Miranda de Castro","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8926-734X","authenticated-orcid":false,"given":"Anna Carolina","family":"Miola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-9294","authenticated-orcid":false,"given":"H\u00e9lio Amante","family":"Miot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2023.09.005_bib0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1590\/S0365-05962012000300012","article-title":"Actinic keratosis: a clinical and epidemiological revision","volume":"87","author":"Schmitt","year":"2012","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2023.09.005_bib0010","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bjd.12420","article-title":"The natural history of actinic keratosis: a systematic review","volume":"169","author":"Werner","year":"2013","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2023.09.005_bib0015","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jamadermatol.2021.0372","article-title":"Ten-year follow-up of persons with sun-damaged skin associated with subsequent development of cutaneous squamous cell carcinoma","volume":"157","author":"Madani","year":"2021","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.abd.2023.09.005_bib0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jaad.2020.03.126","article-title":"Field cancerization: definition, epidemiology, risk factors, and outcomes","volume":"83","author":"Willenbrink","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2023.09.005_bib0025","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/ijd.14767","article-title":"Current therapies for actinic keratosis","volume":"59","author":"Dianzani","year":"2020","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2023.09.005_bib0030","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.abd.2019.10.004","article-title":"Actinic keratoses: review of clinical, dermoscopic, and therapeutic aspects","volume":"94","author":"Reinehr","year":"2019","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2023.09.005_bib0035","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1016\/j.jaad.2021.02.082","article-title":"Guidelines of care for the management of actinic keratosis","volume":"85","author":"Eisen","year":"2021","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2023.09.005_bib0040","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/179663a0","article-title":"Fluorinated pyrimidines, a new class of tumour-inhibitory compounds","volume":"179","author":"Heidelberger","year":"1957","journal-title":"Nature."},{"key":"10.1016\/j.abd.2023.09.005_bib0045","first-page":"153","article-title":"Tumors of the skin. II. Keratoacanthoma; local effct of 5-fluorouracil","volume":"1","author":"Klein","year":"1962","journal-title":"Skin (Los Angeles)."},{"key":"10.1016\/j.abd.2023.09.005_bib0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/09546634.2010.507704","article-title":"Mechanisms of action of topical 5-fluorouracil: review and implications for the treatment of dermatological disorders","volume":"23","author":"Ceilley","year":"2012","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.abd.2023.09.005_bib0055","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/bjd.20570","article-title":"Patient-reported skin reactions to 5% 5-fluorouracil in treatment of actinic keratosis","volume":"185","author":"Ahmady","year":"2021","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2023.09.005_bib0060","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjd.15896","article-title":"Colchicine: an ancient drug with novel applications","volume":"178","author":"Dasgeb","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2023.09.005_bib0065","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000018407","article-title":"Topical colchicine therapy for actinic keratoses","volume":"200","author":"Grima\u00eetre","year":"2000","journal-title":"Dermatology."},{"key":"10.1016\/j.abd.2023.09.005_bib0070","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/1203475415574946","article-title":"Development and validation of a clinical scale for the evaluation of forearm skin photoaging","volume":"19","author":"Guimar\u00e3es","year":"2015","journal-title":"J Cutan Med Surg."},{"key":"10.1016\/j.abd.2023.09.005_bib0075","article-title":"Clinical characteristics of actinic keratoses and their histological correlations: suggestion for a clinical severity scale","volume":"14","author":"Arruda","year":"2022","journal-title":"Surg Cosmet Dermatol."},{"key":"10.1016\/j.abd.2023.09.005_bib0080","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/bjd.16824","article-title":"Effectiveness and safety of 0\u00b75% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial","volume":"179","author":"Miola","year":"2018","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2023.09.005_bib0085","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.abd.2022.04.006","article-title":"Efficacy of oral Polypodium leucotomos, colchicine cream and ingenol mebutate in the treatment of actinic keratoses and cutaneous field cancerization: a randomized clinical trial","volume":"98","author":"Miola","year":"2023","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2023.09.005_bib0090","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/09546630152696314","article-title":"Efficacy and safety assessment of 0.5% and 1% colchicine cream in the treatment of actinic keratoses","volume":"12","author":"Akar","year":"2001","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.abd.2023.09.005_bib0095","first-page":"s4","article-title":"Safety and tolerability of topical agents for actinic keratosis: a systematic review of phase 3 clinical trials","volume":"20","author":"Rajkumar","year":"2021","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.abd.2023.09.005_bib0100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1590\/S1677-54492011000400001","article-title":"Sample size in clinical and experimental trials","volume":"10","author":"Miot","year":"2011","journal-title":"J Vasc Bras."},{"key":"10.1016\/j.abd.2023.09.005_bib0105","article-title":"P-value and effect-size in clinical and experimental studies","volume":"20","author":"Miola","year":"2021","journal-title":"J Vasc Bras."},{"key":"10.1016\/j.abd.2023.09.005_bib0110","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jamadermatol.2015.0502","article-title":"Long-term efficacy of topical fluorouracil cream, 5%, for treating actinic keratosis: a randomized clinical trial","volume":"151","author":"Pomerantz","year":"2015","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.abd.2023.09.005_bib0115","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1056\/NEJMoa1811850","article-title":"Randomized trial of four treatment approaches for actinic keratosis","volume":"380","author":"Jansen","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.abd.2023.09.005_bib0120","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13459","article-title":"Peeling with 70% glicolic acid followed by 5% 5-fluorouracil as well as 5% 5-fluorouracil cream are effective methods for the treatment of actinic keratoses on upper limbs: a randomized clinical trial","volume":"33","author":"Heuser","year":"2020","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.abd.2023.09.005_bib0125","series-title":"The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals","author":"O\u2019Neil","year":"2006"},{"key":"10.1016\/j.abd.2023.09.005_bib0130","series-title":"AHFS Drug Information 2009","year":"2009"},{"key":"10.1016\/j.abd.2023.09.005_bib0135","first-page":"610","article-title":"Five percent 5-fluorouracil in a cream or for superficial peels in the treatment of advanced photoaging of the forearms: a randomized comparative study","volume":"40","author":"Guimar\u00e3es","year":"2014","journal-title":"Dermatol Surg."},{"key":"10.1016\/j.abd.2023.09.005_bib0140","first-page":"35","article-title":"Non-adherence to topical treatments for actinic keratosis","volume":"8","author":"Shergill","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.abd.2023.09.005_bib0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.abd.2021.06.005","article-title":"Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial","volume":"97","author":"Alvares","year":"2022","journal-title":"An Bras Dermatol."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059624000382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059624000382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:51Z","timestamp":1747666851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059624000382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0365059624000382"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2023.09.005","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of 0.5% colchicine cream versus 5% 5-fluorouracil cream in the treatment of cutaneous field cancerization: a randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2023.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}